BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36589824)

  • 1. Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.
    Jiao Z; Wu T; Jiang M; Jiang S; Jiang K; Peng J; Luo G; Yu Y; Chen W; Yang A
    Front Endocrinol (Lausanne); 2022; 13():1094242. PubMed ID: 36589824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer.
    Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
    Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma.
    Park H; Park SY; Park J; Choe JH; Chung MK; Woo SY; Choi JY; Kim SW; Chung JH; Kim TH
    Front Endocrinol (Lausanne); 2021; 12():749973. PubMed ID: 34675884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
    Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
    World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does pretreatment elevated calcitonin level cause the poor prognosis in patients with medullary thyroid cancer?
    Zhang H; Zhang D; Sui C; Li J; Li C; He Q; Du R; Zhao Y; Fu Y; Zhou L; Wang T; Dionigi G; Liang N; Sun H
    Ann Transl Med; 2022 Jun; 10(12):709. PubMed ID: 35845523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
    Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
    Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
    Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
    [No Abstract]   [Full Text] [Related]  

  • 8. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
    Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
    Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
    Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
    PeerJ; 2023; 11():e15025. PubMed ID: 36935920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery.
    Guo F; Li L; Gu P; Zhang G; Ruan X; Zhao J; Zheng X; Wei S; Gao M
    Heliyon; 2024 Apr; 10(8):e29857. PubMed ID: 38681571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
    Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
    Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
    Zhu Q; Xu D
    BMC Cancer; 2021 Apr; 21(1):344. PubMed ID: 33794811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.
    Jung KY; Kim SM; Yoo WS; Kim BW; Lee YS; Kim KW; Lee KE; Jeong JJ; Nam KH; Lee SH; Hah JH; Chung WY; Yi KH; Park DJ; Youn YK; Sung MW; Cho BY; Park CS; Park YJ; Chang HS
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):587-97. PubMed ID: 26175307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
    Kartal Baykan E; Erdoğan M
    Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
    Kesby N; Mechera R; Fuchs T; Papachristos A; Gild M; Tsang V; Clifton-Bligh R; Robinson B; Sywak M; Sidhu S; Chou A; Gill AJ; Glover A
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2626-2634. PubMed ID: 36964913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
    Aksoy YA; Xu B; Viswanathan K; Ahadi MS; Al Ghuzlan A; Alzumaili B; Bani MA; Barletta JA; Chau N; Chou A; Clarkson A; Clifton-Bligh RJ; De Leo A; Dogan S; Ganly I; Ghossein R; Gild ML; Glover AR; Hadoux J; Lamartina L; Lubin DJ; Magliocca K; Najdawi F; Nigam A; Papachristos A; Repaci A; Robinson BG; Sheen A; Shi Q; Sidhu SB; Sioson L; Solaroli E; Sywak MS; Tallini G; Tsang V; Turchini J; Untch BR; Gill AJ; Fuchs TL
    Histopathology; 2024 May; 84(6):947-959. PubMed ID: 38253940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.
    Ho AS; Wang L; Palmer FL; Yu C; Toset A; Patel S; Kattan MW; Tuttle RM; Ganly I
    Ann Surg Oncol; 2015 Aug; 22(8):2700-6. PubMed ID: 25366585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.
    Torresan F; Mian C; Cavedon E; Iacobone M
    Langenbecks Arch Surg; 2019 Jun; 404(4):411-419. PubMed ID: 30903267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.